Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. (Q48402631)

11 February 2018

title

Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. (English)

1 reference

11 February 2018

author name string

Yufeng Zhang

1

1 reference

11 February 2018

Jianyi Li

2

1 reference

11 February 2018

Chohreh Partovian

3

1 reference

11 February 2018

Frank W Sellke

4

1 reference

11 February 2018

Michael Simons

5

1 reference

11 February 2018

publication date

23 January 2003

1 reference

11 February 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

11 February 2018

volume

284

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

H2078-82

1 reference

11 February 2018

Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

A vascular bed-specific pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Regulation of syndecan-4 phosphorylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

The Akt kinase signals directly to endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Fibroblast growth factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Regulation by heparan sulfate in fibroblast growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Fibroblast growth factors: at the heart of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Fibroblast growth factors as multifunctional signaling factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00942.2001

10.1152/AJPHEART.00942.2001

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

12543640

1 reference

11 February 2018